Journal profile · Medicine-Pharmacology (medical)
OpenNano
ISSN 2352-9520 · Elsevier · United States
OpenNano: fully open access; APC about USD 2,380; review about 63 days (submission to acceptance, publisher); 47 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
OpenNano is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Nanoparticle-Based Drug Delivery, Advanced Drug Delivery Systems and Nanoparticles: synthesis and applications, together about 47% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
OpenNano is an internationally peer-reviewed and open-access journal publishing high-quality original research articles and reviews focusing on the application of nanoscience and nanotechnology, with an emphasis on conceptual novelty and scientific quality.OpenNano publishes research from basic to translational and clinical settings with the aim to bring together pharmaceutical scientists, chemists, biotechnologists, material scientists, pharmacologists, clinicians and all others working in this exciting and challenging area.The journal publishes topics including:NanoparticlesPolymeric NanoparticlesLiposomes and Solid Lipid NanoparticlesNanovesciclesExosomesNanostructured MaterialsNanocrystals and Quantum DotsNanotubes and Nanoporous MaterialsFunctional NanomaterialsNanosystemsNanodevicesSelf-Assembly
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pharmacology (medical)
Editor-in-chief Luca CasettariPublisher website
Editorial board by country: 1 in mainland China (about 4%); most named Germany 5, United States 4, Australia 4, United Kingdom 2, Italy 2 (26 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoparticle-Based Drug DeliveryMaterials Science22.3%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics12.5%
- Nanoparticles: synthesis and applicationsMaterials Science12.3%
- Nanoplatforms for cancer theranosticsEngineering6.4%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics5.6%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5.5%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.1%
- Gold and Silver Nanoparticles Synthesis and ApplicationsMaterials Science4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacology (medical) | Q1 | 6/278 | 98th |
| Pharmaceutical Science | Q1 | 7/191 | 96th |
| Internal Medicine | Q1 | 9/179 | 95th |
| Biotechnology | Q1 | 19/325 | 94th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 17.3LetPub ·
- CiteScore (publisher)
- 17.3Publisher website ·
- SJR 2026-06
- 1.18LetPub ·
- SNIP 2026-06
- 1.34LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 163OpenAlex ·
- 2-year mean citedness
- 5.75OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 313 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 46 | 46 | 1,687 |
| 2025 | 47 | 47 | 2,142 |
| 2024 | 28 | 28 | 1,734 |
| 2023 | 76 | 76 | 1,086 |
| 2022 | 80 | 80 | 421 |
| 2021 | 4 | 4 | 333 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
63 dayssubmission to acceptance · community reports about 12 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- First decision after review
- 29 daysPublisher website ·
- Submission to acceptance
- 63 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,380 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 1,860 / EUR 1,740 / GBP 1,490 / JPY 230,700 | — | — | |
| LetPub | USD 2,160 | Yes | — | |
| Publisher website | USD 2,980 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted4, with length limits
- hypothesisCOMMUNICATIONS: Communications are to disseminate new observations quickly to the scientific community. Length of communications should not exceed 1,500 words (…Length not stated
- opinionCOMMUNICATIONS: Communications are to disseminate new observations quickly to the scientific community. Length of communications should not exceed 1,500 words (…Length not stated
- original articleCOMMUNICATIONS: Communications are to disseminate new observations quickly to the scientific community. Length of communications should not exceed 1,500 words (…Length not stated
- reviewCOMMUNICATIONS: Communications are to disseminate new observations quickly to the scientific community. Length of communications should not exceed 1,500 words (…main text ≤ 12,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United States
- Language
- English
- ISSN
- 2352-9520
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about OpenNano
How long does peer review take at OpenNano?
The publisher reports about 63 days (submission to acceptance); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of OpenNano?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Numbered, in order of citation; Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of OpenNano based?
Of the 26 board members whose country the journal's board page names, 1 (about 4%) are in mainland China; the countries named most often are Germany (5), United States (4) and Australia (4). Counted from the institutions listed on the board page; for reference only.
Which databases index OpenNano?
According to LetPub and DOAJ records, OpenNano is indexed in Scopus and DOAJ.
Is OpenNano open access, and what is the APC?
OpenNano is a fully open-access journal. APC about USD 2,380.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .